CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,634,611 | -38.2% | 972,861 | +4.1% | 0.00% | – |
| Q2 2023 | $2,644,074 | -39.7% | 934,302 | +4.7% | 0.00% | -100.0% |
| Q1 2023 | $4,381,286 | +47486.5% | 892,319 | +4.1% | 0.00% | 0.0% |
| Q4 2022 | $9,207 | -99.9% | 857,335 | +4.5% | 0.00% | 0.0% |
| Q3 2022 | $7,676,000 | +2.8% | 820,174 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $7,470,000 | -23.6% | 818,229 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $9,776,000 | -4.6% | 804,625 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $10,243,000 | -20.8% | 841,028 | +0.5% | 0.00% | -50.0% |
| Q3 2021 | $12,934,000 | +14.4% | 837,156 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $11,308,000 | -27.9% | 792,443 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $15,673,000 | +53.3% | 721,938 | +6.8% | 0.00% | 0.0% |
| Q4 2020 | $10,226,000 | +24.6% | 675,891 | +4.8% | 0.00% | 0.0% |
| Q3 2020 | $8,206,000 | -24.0% | 644,923 | +2.1% | 0.00% | 0.0% |
| Q2 2020 | $10,803,000 | +34.4% | 631,764 | +3.8% | 0.00% | 0.0% |
| Q1 2020 | $8,037,000 | -53.8% | 608,414 | -43.7% | 0.00% | 0.0% |
| Q4 2019 | $17,412,000 | +81.3% | 1,080,920 | +105.8% | 0.00% | 0.0% |
| Q3 2019 | $9,602,000 | +0.1% | 525,275 | +17.7% | 0.00% | 0.0% |
| Q2 2019 | $9,596,000 | +22.9% | 446,353 | +12.2% | 0.00% | 0.0% |
| Q1 2019 | $7,807,000 | -18.5% | 397,950 | -46.0% | 0.00% | +100.0% |
| Q4 2018 | $9,574,000 | +15.0% | 736,612 | +111.9% | 0.00% | -50.0% |
| Q3 2018 | $8,326,000 | +74.0% | 347,659 | +39.1% | 0.00% | +100.0% |
| Q2 2018 | $4,786,000 | +68.8% | 249,953 | +9.1% | 0.00% | 0.0% |
| Q1 2018 | $2,835,000 | +2.6% | 229,055 | +1.5% | 0.00% | 0.0% |
| Q4 2017 | $2,763,000 | -9.3% | 225,774 | +1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,045,000 | -9.6% | 222,440 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $3,367,000 | -1.6% | 218,781 | +17.6% | 0.00% | 0.0% |
| Q1 2017 | $3,422,000 | +107.8% | 186,106 | +5.0% | 0.00% | 0.0% |
| Q4 2016 | $1,647,000 | +45.8% | 177,313 | +31.0% | 0.00% | 0.0% |
| Q3 2016 | $1,130,000 | +97.2% | 135,339 | +13.5% | 0.00% | – |
| Q2 2016 | $573,000 | -20.5% | 119,201 | +2.7% | 0.00% | – |
| Q1 2016 | $721,000 | -62.5% | 116,068 | +1.9% | 0.00% | -100.0% |
| Q4 2015 | $1,921,000 | +19.8% | 113,954 | +1.5% | 0.00% | 0.0% |
| Q3 2015 | $1,604,000 | +113.0% | 112,301 | +81.0% | 0.00% | – |
| Q2 2015 | $753,000 | +41.3% | 62,044 | +16.8% | 0.00% | – |
| Q1 2015 | $533,000 | +13.2% | 53,119 | +12.2% | 0.00% | – |
| Q4 2014 | $471,000 | +25.9% | 47,337 | +5.9% | 0.00% | – |
| Q3 2014 | $374,000 | -28.1% | 44,682 | +46.2% | 0.00% | – |
| Q2 2014 | $520,000 | -7.3% | 30,560 | +1.3% | 0.00% | – |
| Q1 2014 | $561,000 | – | 30,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |